$AARD 4 SEC Filings

Filed On	Filing
08 Oct 2026	Form 4: Zhang Zhongwei, Director Granted 127,061 Stock Option (right to buy)
11 Sep 2026	Form 4: Sun Nelson, See Remarks Sold 14,754 shares ($73.8K) · Sold 62,000 shares ($321K)
21 Aug 2026	Form 4: Chi Jeffrey, Director Granted 44,964 Stock Option (right to buy)
21 Aug 2026	Form 4: Graf Susan E, Director Granted 44,964 Stock Option (right to buy)
21 Aug 2026	Form 4: Baynes Roy D., Director Granted 44,964 Stock Option (right to buy)
21 Aug 2026	Form 4: Tong Victor Edward Jr, Director Granted 44,964 Stock Option (right to buy)
11 Feb 2026	Form 4: Sun Nelson, Chief Financial Officer Disposed of 70,549 Stock option (right to buy) (Grant/Award Acquisition)
11 Feb 2026	Form 4: Jaiman Manasi, Chief Medical Officer Disposed of 70,549 Stock option (right to buy) (Grant/Award Acquisition)
11 Feb 2026	Form 4: Lee Tien-Li, Director Disposed of 203,851 Stock option (right to buy) (Grant/Award Acquisition)
12 Dec 2025	Form 4: Sun Nelson, Chief Financial Officer Bought 3,000 shares ($43.2K)
12 Dec 2025	Form 4: Lee Tien-Li, Director Bought 7,000 shares ($101K)
16 Oct 2025	Form 4: Lee Tien-Li, Director Received 1,229 shares by exercise or conversion ($5.21K)
16 Oct 2025	Form 4: Jones Bryan, Chief Operating Officer Received 1,250 shares by exercise or conversion ($5.3K)
16 Sep 2025	Form 4: Lee Tien-Li, Director Bought 10,000 shares ($96.6K)
12 Sep 2025	Form 4: Lee Tien-Li, Director Bought 9,000 shares ($71.2K) · Bought 6,000 shares ($46.9K) · Bought 5,000 shares ($42.5K)
10 Sep 2025	Form 4: Sun Nelson, Chief Financial Officer Bought 6,000 shares ($48.4K)
29 Aug 2025	Form 4: Lee Tien-Li, Director Received 17,209 shares by exercise or conversion ($73K)
13 Jun 2025	Form 4: Lee Tien-Li, Director Granted 549,534 Stock option (right to buy)
13 Jun 2025	Form 4: Chi Jeffrey, Director Granted 61,017 Stock Option (right to buy)
13 Jun 2025	Form 4: Jaiman Manasi, Chief Medical Officer Granted 126,999 Stock Option (right to buy)

Comments